InMode Ltd (INMD)

InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial OfficerMay 20, 2026 7:00 AM
PR Newswire (US) YOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies, today announced the appointment of Dr. Shlomo Nass as Chairman of the Company's Board of Directors (the "Board") and Moshik Itzkovich as Chief Financial Officer, effective immediately. Dr. Nass succeeds Dr. Michael Anghel, who retired earlier this month, and will lead the Board in supporting the Company's long-term strategic growth and governance priorities. Dr. Nass brings decades of expertise in corporate law, accounting, governance, and audit oversight, with extensive experience advising public and private companies on complex regulatory and financial matters."We are pleased to welcome Shlomo as Chairman of the Board," said Moshe Mizrahy, Chief Executive Officer. "His deep expertise in corporate governance, financial oversight, and regulatory matters, combined with his extensive leadership experience, will be invaluable as we continue to execute our strategic priorities and drive long-term shareholder value.""On behalf of the Board and management team, we thank Michael Anghel for his many years of commitment and service to InMode and wish him all the best going forward," Mizrahy concluded.At the same time, InMode announced the appointment of Moshik Itzkovich as Chief Financial Officer. Moshik has held senior finance roles at InMode and was previously Senior Vice President of Finance. He replaces Yair Malca, who stepped down earlier this month and will serve as a consultant at least through the Company's Annual General Meeting to ensure a smooth transition."Having partnered closely with Yair over the last three years, Moshik brings continuity, financial expertise, and strategic insight to this role," said Moshe Mizrahy, Chief Executive Officer. "We are confident he is well positioned to build on our strong financial foundation and support the Company's long-term objectives.""We thank Yair for his many years of exceptional service. His leadership and contributions have been instrumental to our success, and he played a key role in our transition to a publicly traded Company. He leaves InMode with a very strong balance sheet and solid operational and financial foundations in place for his successor. We are grateful for his lasting impact on the Company," Mizrahy concluded.About InMode InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Forward-Looking Statements The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.Investor Relations Contact:Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.comLogo - https://mma.prnewswire.com/media/1064477/5978883/InMode_Logo.jpg View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.htmlSOURCE InMode LTD Original: InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year IncreaseMay 6, 2026 7:00 AM
PR Newswire (US) YOKNEAM, Israel, May 6, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter of 2026. First Quarter 2026 Highlights:
?  Quarterly GAAP revenues of $82.0 million, compared to $77.9 million in the first quarter of 2025.
?  Quarterly revenues from consumables and service of $21.4 million, an increase of 6% compared to the first quarter of 2025.?  GAAP operating income of $10.1 million, *non-GAAP operating income of $14.0 million.?  Total cash position of $537.2 million as of March 31, 2026, including cash and cash equivalents, marketable securities and short-term bank deposits.?  As of March 31, 2026, we completed the repurchase of 2.55 million ordinary shares pursuant to our share repurchase program, returning $34.8 million of capital to shareholders ($3.6 million of which was paid during the second quarter of 2026).?  Announced CFO transition; Yair Malca steps down and will support an orderly transition as a consultant.?  Board transition: Dr. Michael Anghel resigns; Dr. Hadar Ron appointed Interim Chair of the Board. U.S. GAAP Results(U.S. dollars in thousands, except for per share data)
Q1 2026Q1 2025Revenues$82,017$77,874Gross Margins75 %78 %Operating Margins12 %20 %Net Income $11,562$18,201Earnings per Diluted Share$0.18$0.26*Non-GAAP Results(U.S. dollars in thousands, except for per share data)
Q1 2026Q1 2025Gross Margins75 %79 %Operating Margins17 %23 %Net Income $15,872$21,395Earnings per Diluted Share$0.25$0.31*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A
reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements included in this release.
Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-
recurring cost) and related income tax adjustments where applicable. Management Comments"While the macroeconomic environment remains challenging, our total revenue this quarter reached our expectations, however our profitability was lower than expected," said Moshe Mizrahy, Chief Executive Officer of InMode.  "We are continuing to re-shape our organization in North America and in Europe by enhancing our sales and management teams. While the demand in the aesthetics market may be deferred, it will not be diminished, and we believe we are well positioned for its return."First Quarter 2026 Financial ResultsTotal GAAP revenues for the first quarter of 2026 were $82.0 million, an increase of 5% compared to $77.9 million in the first quarter of 2025. Yair Malca, Chief Financial Officer of InMode added, "We are encouraged to report that Q1 revenue increased 5% year over year, with the U.S. contributing meaningfully to this growth. These results reflect our ability to execute consistently, even in a softer market environment and expand outside of the U.S."GAAP gross margin for the first quarter of 2026 was 75%, compared to 78% for the first quarter of 2025.*Non-GAAP gross margin for the first quarter of 2026 was 75%, compared to 79% for the first quarter of 2025.GAAP operating margin for the first quarter of 2026 was 12%, compared to 20% in the first quarter of 2025.
*Non-GAAP operating margin for the first quarter of 2026 was 17%, compared to 23% for the first quarter of 2025. These decreases were primarily attributable to the increase in cost of goods, the new structure of the North America sales team implemented towards end of 2025 and subsidiary establishments in the latter part of 2025.InMode reported GAAP net income of $11.6 million, or $0.18 per diluted share, in the first quarter of 2026, compared to $18.2 million, or $0.26 per diluted share, in the first quarter of 2025. On a *non-GAAP basis, InMode reported net income of $15.9 million, or $0.25 per diluted share, in the first quarter of 2026, compared to $21.4 million, or $0.31 per diluted share, in the first quarter of 2025.As of March 31, 2026, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $537.2 million."In a quarter marked by ongoing macroeconomic uncertainty, we remained focused on what we can control: driving profitability, generating cash, and operating the business as usual. We also returned meaningful capital to shareholders, repurchasing $127.4 million of shares during 2025 and $52.7 million year to date under our new 2026 repurchase program, representing 3.86 million shares. With our strong financial position and continued flexibility, we remain well positioned to pursue a full range of capital allocation opportunities," concluded Malca.Departure of Chairman; Resignation of Chief Financial OfficerThe Company announced today that Dr. Michael Anghel has resigned from the Company's Board of Directors, effective May 5, 2026. His decision was not related to any disagreements with the Company's management, Board, or operations. The Company thanks Dr. Anghel for his service and wishes him continued success.Dr. Hadar Ron has been appointed Interim Chair of the Board, effective immediately.Separately, Yair Malca has stepped down from his role as Chief Financial Officer, effective May 5, 2026. The Company appreciates his contributions and thanks him for his service.To support a smooth transition, Mr. Malca will remain engaged with the Company in a consulting capacity for at least six months.2026 Financial Outlook Management provided an outlook for the full fiscal year ending December 31, 2026. Based on current estimates, management expects:Revenues between $365 million and $375 million*Non-GAAP gross margin between 74% and 76%*Non-GAAP income from operations to be between $73 million and $78 million*Non-GAAP earnings per diluted share between $1.33 and $1.38This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable.However, these estimates are based on management's current estimates, which may be updated. The Current Situation in IsraelRegarding the current situation in Israel, on October 9, 2025, a new cease-fire agreement between Hamas and Israel began, and the hostilities have formally paused after two years of conflicts.Moreover, On February 28, 2026, the United States and Israel launched coordinated joint military strikes against Iran, targeting military, governmental, and nuclear-related sites. Iran subsequently responded with missile and drone attacks against targets in the region and sought to restrict commercial shipping traffic through the Strait of Hormuz. On April 7, 2026, a two-week ceasefire established and was extended on April 21, 2026, by the U.S government, amid ongoing negotiations, while a U.S. naval blockade of Iran continued.The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. Use of Non-GAAP Financial MeasuresIn addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin, non-GAAP gross margin and non-GAAP income from operations. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release. Reconciliations of non-GAAP gross margin, non-GAAP income, and non-GAAP earnings for management's projections of such non-GAAP financials for the 2026 fiscal year are not available without unreasonable effort due to the variability, complexity and limited visibility of certain reconciling items. These reconciling items could have a significant and unpredictable impact on our future GAAP results.Conference Call InformationMr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer and Mr. Yair Malca, Chief Financial Officer, will host a conference call today, May 6, 2026, at 8:30 a.m. Eastern Time to discuss the first quarter 2026 financial results.The Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10207930/103b6ad5664.Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.U.S./Canada Toll-Free Dial-in Number: 1-833-316-0562
Israel Toll-Free Dial-in Number: 1-80-921-2373
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=7s0HUsXwAt:
8:30 a.m. Eastern Time
5:30 a.m. Pacific TimeThe conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from May 6, 2026, at 12 p.m. Eastern Time to May 20, 2026, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: Replay Dial-in U.S. /Canada TOLL-FREE: 1-855-669-9658
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 8622780To access the replay using an international dial-in number, please select the link below:https://services.choruscall.com/ccforms/replay.htmlA replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.About InModeInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.Forward-Looking Statements The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.Company Contact:Yair MalcaChief Financial OfficerPhone: (949) 305-0108Email: Yair.Malca@inmodemd.com Investor Relations Contact:Miri SegalMS-IR LLCEmail: ir@inmodemd.com  INMODE LTD.CONDENSED CONSOLIDATED STATEMENTS OF INCOME(U.S. dollars in thousands, except for per share data)(Unaudited)
Three months endedMarch 31,
2026
2025REVENUES82,017
77,874COST OF REVENUES20,465
16,963GROSS PROFIT61,552
60,911OPERATING EXPENSES:


Research and development3,542
2,895Sales and marketing42,932
39,727General and administrative5,022
2,671TOTAL OPERATING EXPENSES51,496
45,293OPERATING INCOME10,056
15,618Finance income, net4,296
6,859INCOME BEFORE INCOME TAXES14,352
22,477INCOME TAXES2,790
4,276NET INCOME11,562
18,201



EARNINGS PER SHARE:


Basic0.18
0.26Diluted0.18
0.26WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING USED IN COMPUTATION OF EARNINGS PER
SHARE (in thousands)


Basic63,401
68,760Diluted63,942
69,435  INMODE LTD.CONDENSED CONSOLIDATED BALANCE SHEETS(U.S. dollars in thousands, except for per share data)(Unaudited)
March 31,2026December 31,2025Assets

CURRENT ASSETS:

Cash and cash equivalents394,295302,543Marketable securities 57,03283,632Short-term bank deposits85,832169,159Accounts receivable, net of allowance for credit losses40,70343,504Prepaid expenses and other receivables31,50925,733Inventories71,40874,050         TOTAL CURRENT ASSETS680,779698,621    NON-CURRENT ASSETS:

Accounts receivable, net of allowance for credit losses 5,2103,005Deferred income tax assets52,92253,230Operating lease right-of-use assets 8,6318,274Property and equipment, net2,5952,599Other investments700700TOTAL NON-CURRENT ASSETS70,05867,808TOTAL ASSETS750,837766,429Liabilities and shareholders' equity

CURRENT LIABILITIES:

Accounts payables16,85317,912Contract liabilities16,36912,093Other liabilities44,13140,739TOTAL CURRENT LIABILITIES77,35370,744    NON-CURRENT LIABILITIES:

Contract liabilities2,7453,043Other liabilities4,6574,436Operating lease liabilities4,8295,008TOTAL NON-CURRENT LIABILITIES12,23112,487TOTAL LIABILITIES89,58483,231


TOTAL SHAREHOLDERS' EQUITY661,253683,198TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY750,837766,429  INMODE LTD.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(U.S. dollars in thousands, except for per share data)(Unaudited)




Three months endedMarch 31,

2026
2025CASH FLOWS FROM OPERATING ACTIVITIES:





Net income

11,562

18,201Adjustments required to reconcile net income to net cash provided by operating activities:





Depreciation and amortization

175

174Share-based compensation expenses

2,699

2,518Change in allowance for credit losses of trade receivable

525

(94)Gains on marketable securities, net

–

(2)Finance expenses (income), net

719

(1,574)Deferred income taxes, net

327

896Changes in operating assets and liabilities:





Decrease in accounts receivable (current and non-current)

72

4,544Increase in other receivables

(5,866)

(3,532)Decrease (increase) in inventories

2,642

(4,233)Increase (decrease) in accounts payable

(1,059)

1,270Decrease in other liabilities (current and non-current)

(388)

(3,287)Increase (decrease) in contract liabilities (current and non-current)

3,978

(837)Net cash provided by operating activities

15,386

14,044CASH FLOWS FROM INVESTING ACTIVITIES:





Investment in short-term deposits

(84,912)

–Proceeds from short-term deposits

167,658

31,297Purchase of fixed assets

(172)

(85)Purchase of marketable securities

(9,727)

(20,877)Proceeds from sale of marketable securities

–

3,003Proceeds from maturity of marketable securities

36,256

62,147Net cash provided by investing activities

109,103

75,485CASH FLOWS FROM FINANCING ACTIVITIES:





Tax withholding related to vesting of restricted share units

(1,802)

-Repurchase of ordinary shares

(31,241)

(99,960)Exercise of options

617

494Net cash used in financing activities

(32,426)

(99,466)EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH
    EQUIVALENTS

 (311)

 556NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

91,752

(9,381)






CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

302,543

155,329CASH AND CASH EQUIVALENTS AT END OF PERIOD

394,295

145,948  INMODE LTD.CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS(U.S. dollars in thousands, except for per share data)(Unaudited)


Three months ended March 31,20262025Revenues by Category:










Capital Equipment revenues - United States33,66941 %29,54238 %
Capital Equipment revenues - International26,98533 %28,13336 %
Total Capital Equipment revenues60,65474 %57,67574 %
Consumables and service revenues21,36326 %20,19926 %
Total Revenue82,017100 %77,874100 %
 
Three months ended March 31,20262025
%%
United
StatesInternationalTotalUnited
StatesInternationalTotalRevenues by Technology:





Minimal-Invasive758077937987Hands-Free 111323Non-Invasive24192241910
100100100100100100  INMODE LTD.RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME (U.S. dollars in thousands, except for per share data)(Unaudited)







Three months ended March 31, 2026
Three months ended March 31, 2025


GAAP
Stock Based
Compensation
Expenses
Related to
Independent
Transaction
Committee Review
Non-GAAP
GAAP
Stock Based
Compensation
Non-GAAPREVENUES
82,017
–
–
82,017
77,874
–
77,874COST OF REVENUES
20,465
(314)
–
20,151
16,963
(310)
16,653GROSS PROFIT
61,552
314
–
61,866
60,911
310
61,221OPERATING EXPENSES:













Research and development
3,542
(268)
–
3,274
2,895
(222)
2,673Sales and marketing
42,932
(1,861)
–
41,071
39,727
(1,763)
37,964General and administrative
5,022
(256)
(1,262)
3,504
2,671
(223)
2,448TOTAL OPERATING EXPENSES
51,496
(2,385)
(1,262)
47,849
45,293
(2,208)
43,085OPERATING INCOME
10,056
2,699
1,262
14,017
15,618
2,518
18,136Finance income, net
4,296
–
–
4,296
6,859
–
6,859INCOME BEFORE INCOME TAXES
14,352
2,699
1,262
18,313
22,477
2,518
24,995INCOME TAXES
2,790
(349)
–
2,441
4,276
(676)
3,600NET INCOME
11,562
3,048
1,262
15,872
18,201
3,194
21,395














EARNINGS PER SHARE













Basic
0.18




0.25
0.26


0.31Diluted
0.18




0.25
0.26


0.31WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING USED IN
COMPUTATION OF NET INCOME PER
SHARE (in Thousands)













Basic
63,401




63,401
68,760


68,760Diluted
63,942




64,494
69,435


69,611 Logo - https://mma.prnewswire.com/media/1064477/5954733/InMode_Logo.jpg View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-reports-first-quarter-2026-financial-results-quarterly-gaap-revenue-of-82-million-represents-5-year-over-year-increase-302763182.htmlSOURCE InMode LTD. Original: InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375MApril 13, 2026 7:00 AM
PR Newswire (US)

Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter of 2026 before the Nasdaq market opens on Wednesday, May 6, 2026.







InMode is currently finalizing its financial results for the first quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode's financial results for such period, subject to final adjustments and other developments that may arise between now and the time such financial results are finalized. Based on preliminary results, management expects:Revenue for the first quarter of 2026 to be in the range of $81.5 million to $81.7 millionNon-GAAP1 gross margin to be in the range of 75% to 76%Full year 2026 revenue to be in the range of $365 million to $375 million1Please refer to "Use of Non-GAAP Financial Measure" below for important information about non-GAAP financial measures. Non-GAAP gross margin excludes share-based compensation.InMode will host a conference call to discuss the first quarter 2026 financial results on Wednesday, May 6 at 8:30 a.m. Eastern Time. Speakers on the call will include Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer and Dr. Michael Kreindel, Chief Technology Officer.The Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10207930/103b6ad5664. Callers will receive a unique dial-in upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.For callers that opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.U.S. Toll-Free: 1-833-316-0562
Israel Toll-Free: 1-80-921-2373
International: 1-412-317-5736                                                                                      Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=7s0HUsXwAt:
8:30 a.m. Eastern Time
5:30 a.m. Pacific TimeThe conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from May 6, 2026, at 12:00 p.m. Eastern Time to May 20, 2026, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers:Replay U.S. TOLL-FREE: 1-855-669-9658
Replay TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 8622780A replay will also be available for 90 days on InMode's website at: https://inmodemd.com/investors/events-presentations/. About InModeInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.Forward-Looking Statements The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.Use of Non-GAAP Financial MeasuresIn addition to InMode's operating results presented in accordance with GAAP, this release includes non-GAAP gross margin. Because this measure is used in InMode's internal analysis of financial and operating performance, management believes that it provides greater transparency to investors of management's view of InMode's economic performance. Management also believes the presentation of this measure, when analyzed in conjunction with InMode's GAAP operating results, allows investors to evaluate and compare the performance of InMode to that of its peers, although InMode's presentation of its non-GAAP measure may not be comparable to other similarly titled measures of other companies more effectively.Company Contact:Yair MalcaChief Financial OfficerEmail: Yair.Malca@inmodemd.comInvestor Relations Contact:Miri SegalMS-IR LLCEmail: ir@inmodemd.comLogo - https://mma.prnewswire.com/media/1064477/5910753/InMode_Logo.jpg



View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-report-first-quarter-2026-financial-results-and-hold-conference-call-on-may-6--2026--expects-q1-revenue-between-81-5m-81-7m-reiterates-fy-2026-revenue-guidance-between-365m-375m-302739483.htmlSOURCE InMode LTD.

Original: InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

InMode Announces New Share Repurchase ProgramMarch 13, 2026 7:00 AM
PR Newswire (US)

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.







In 2025, the Company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the Company continues to generate strong cash flow and believes that repurchasing shares at its current valuation represents an attractive use of capital.While management remains focused on navigating the ongoing regional conflict and maintaining a disciplined approach to capital allocation, the Company will continue to evaluate additional share repurchase programs and other capital allocation opportunities going forward.The Company expects to fund repurchases under the program with available cash. Repurchases may be made from time to time in the open market or through other permitted means, subject to market conditions and applicable legal requirements. The program may be modified, suspended, or discontinued at any time at the Company's discretion.About InModeInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com/.Forward-Looking StatementsThe information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.Company Contact:Yair MalcaChief Financial OfficerPhone: (949) 305-0108Email: Yair.Malca@inmodemd.comInvestor Relations Contact       Miri SegalMS-IR LLCEmail: ir@inmodemd.comLogo - https://mma.prnewswire.com/media/1064477/5862039/InMode_Logo.jpg



View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-announces-new-share-repurchase-program-302712849.htmlSOURCE InMode Ltd.

Original: InMode Announces New Share Repurchase Program

InMode Announces Conclusion of Independent Transaction Committee ReviewFebruary 23, 2026 7:00 AM
PR Newswire (US)

YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent transaction committee of its Board of Directors (the "Committee") has completed its review of proposals received in connection with a potential transaction.
 Since its formation, the Committee has conducted a comprehensive and independent process to evaluate proposals received over the course of its work, with the assistance of external financial and legal advisors.Following a careful review of the final proposals received in connection with the potential transaction, the Committee has concluded that none of the final proposals is adequate and in the best interests of the Company and its shareholders. Accordingly, the Committee has determined to discontinue the process at this time.The Company will continue to review and evaluate its business and growth strategy, as well as its cash allocation strategy, with a focus on enhancing long-term shareholder value.The Company does not intend to provide further updates regarding this matter unless and until it determines that additional disclosure is appropriate or required.About InModeInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.Forward-Looking StatementsThe information in this press release includes forward-looking statements within the meaning of the federal securities laws. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpgContactsMiri Segal
MS-IR LLC
ir@inmodemd.com



View original content:https://www.prnewswire.com/news-releases/inmode-announces-conclusion-of-independent-transaction-committee-review-302694503.htmlSOURCE InMode Ltd.

Original: InMode Announces Conclusion of Independent Transaction Committee Review

InMode slips after cautious 2026 outlook outweighs Q4 beatFebruary 10, 2026 11:10 AM
IH Market News
InMode Ltd. (NASDAQ:INMD) reported fourth-quarter earnings and revenue on Tuesday that came in ahead of expectations, but its weaker-than-anticipated guidance for 2026 weighed on investor sentiment.Shares of the medical technology company fell 3.37% in pre-market trading following the announcement.For the quarter, InMode delivered adjusted earnings of $0.46 per share, topping the analyst consensus of $0.42. Revenue reached $103.85 million, beating estimates of $101.7 million and rising 6% from $97.9 million in the same period last year.Despite the solid quarterly performance, the stock moved lower after the company issued full-year 2026 guidance below Wall Street forecasts. InMode expects adjusted earnings per share of $1.43 to $1.48 on revenue of $365 million to $375 million. Analysts had been looking for $1.64 in EPS and $373.9 million in revenue.“While conditions across our industry remain challenging, we are seeing early signs of stabilization,” said Moshe Mizrahy, Chief Executive Officer of InMode. “While the global uncertainties, particularly in North America, continue to weigh on overall demand, and the industry has yet to fully rebound, we are encouraged by the initial growth in Europe.”For full-year 2025, InMode reported revenue of $370.5 million, down 6% year over year. Offsetting some of that pressure, consumables and service revenue increased 3% to $81.4 million compared with 2024.Chief Financial Officer Yair Malca highlighted strong momentum in Europe. “Our European operations achieved record revenue in the fourth quarter, reflecting continued momentum across the region and strong execution by our teams,” Malca said.InMode ended 2025 with a robust cash balance of $555.3 million and returned $127.4 million to shareholders through share repurchases during the year.Looking ahead, the company plans to introduce two new laser-based platforms in 2026, which management believes will help reinforce its long-term competitive position.InMode stock price

Original: InMode slips after cautious 2026 outlook outweighs Q4 beat

InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 MillionFebruary 10, 2026 7:00 AM
PR Newswire (US)

YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025.Fourth Quarter 2025 Highlights:Quarterly GAAP revenues of $103.9 million, compared to $97.9 million in the fourth quarter of 2024.Quarterly revenues from consumables and service of $21.5 million, an increase of 8% compared to the fourth quarter of 2024.GAAP operation income of $26 million, *non-GAAP operation income of $28.5 million.Total cash position of $555.3 million as of December 31, 2025, including cash and cash equivalents, marketable securities and short-term bank deposits.Full Year 2025 Highlights:Full year revenues of $370.5 million, a year-over-year decrease of 6%.Full year revenues from consumables and service of $81.4 million, an increase of 3% compared to 2024.GAAP operation income of $85.4 million, compared to $112.5 million in 2024; *non-GAAP operation income of $96.5 million, compared to $129.1 million in 2024.Returned $127.4 million of capital to shareholders through repurchase of ordinary shares during 2025. U.S. GAAP Results(U.S. dollars in thousands, except for per share data)
Q4 2025Q4 2024FY 2025FY 2024Revenues$103,854$97,853$370,495$394,818Gross Margins78 %79 %79 %80 %Net Income $27,025$82,771$93,831$181,275Earnings per Diluted Share$0.42$1.14$1.43$2.25*Non-GAAP Results(U.S. dollars in thousands, except for per share data)
Q4 2025Q4 2024FY 2025FY 2024Gross Margins79 %80 %79 %81 %Net Income $29,429$31,081$105,495$142,707Earnings per Diluted Share$0.46$0.42$1.60$1.76*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of
Income is provided following the financial statements included in this release. Non-GAAP results exclude share-based compensation and tax benefit adjustments. Management Comments"While conditions across our industry remain challenging, we are seeing early signs of stabilization," said Moshe Mizrahy, Chief Executive Officer of InMode. "While the global uncertainties, particularly in North America, continue to weigh on overall demand, and the industry has yet to fully rebound, we are encouraged by the initial growth in Europe.""Looking ahead, in 2026 we plan on launching two new laser-based platforms. We see solid potential for these offerings across both our existing customer base and new customers and believe they will further strengthen our long-term market position," concluded Mizrahy."Over the past year, we have unified our North American operations into a single organization encompassing the Eastern U.S., Western U.S., and Canada," said Michael Dennison, President of North America. "At the same time, we have refreshed our sales and post-sales leadership teams, strengthening our ability to serve customers across the region. With this foundation in place, we are entering 2026 with focus, alignment, and clear direction."Fourth Quarter and Full Year 2025 Financial ResultsTotal GAAP revenues for the fourth quarter of 2025 were $103.9 million, an increase of 6% compared to $97.9 million in the fourth quarter of 2024. Total revenues for 2025 were $370.5 million, a decrease of 6% compared to 2024.Yair Malca, Chief Financial Officer of InMode added, "Our European operations achieved record revenue in the fourth quarter, reflecting continued momentum across the region and strong execution by our teams."GAAP gross margin for the fourth quarter of 2025 was 78%, compared to 79% for the fourth quarter of 2024. *Non-GAAP gross margin for the fourth quarter of 2025 was 79%, compared to 80% for the fourth quarter of 2024. GAAP gross margin for 2025 was 79%, compared to 80% for 2024. *Non-GAAP gross margin for 2024 was 79%, compared to 81% for 2024.GAAP operating margin for the fourth quarter of 2025 was 25%, compared to 28% in the fourth quarter of 2024. *Non-GAAP operating margin for the fourth quarter of 2025 was 27%, compared to 32% for the fourth quarter of 2024. GAAP operating margin for 2025 was 23%, compared to 29% in 2024. *Non-GAAP operating margin for 2025 was 26%, compared to 33% in the full year of 2024. This decrease was primarily attributable to higher sales and marketing expenses.InMode reported GAAP net income of $27.0 million, or $0.42 per diluted share, in the fourth quarter of 2025, compared to $82.8 million, or $1.14 per diluted share, in the fourth quarter of 2024. On a *non-GAAP basis, InMode reported net income of $29.5 million, or $0.46 per diluted share, in the fourth quarter of 2025, compared to $31.1 million, or $0.42 per diluted share, in the fourth quarter of 2024. GAAP net income was $93.9 million, or $1.43 per diluted share, in 2025, compared to GAAP net income of $181.3 million, or $2.25 per diluted share, in 2024. On a *non-GAAP basis, InMode reported net income of $105.5 million, or $1.60 per diluted share, in the full year of 2025, compared to net income of $142.7 million, or $1.76 per diluted share, for the full year in 2024. As a reminder, during Q4 of 2024, the Company released a valuation allowance related to its U.S. net deferred tax assets, and as a result recorded a one-time deferred tax asset of $55.1 million. Therefore, non-GAAP net income represents the most efficient basis for the comparison of year-over-year net results.As of December 31, 2025, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $555.3 million."We ended the year with a strong balance sheet and returned $127.4 million of capital to shareholders through the repurchase of ordinary shares during 2025, underscoring our disciplined capital allocation and commitment to shareholder value," concluded Malca.2026 Financial Outlook Management provided an outlook for the full year of 2026 ending December 31, 2026. Based on current estimates, management expects:Revenues between $365 million to $375 million*Non-GAAP gross margin between 75% and 77%*Non-GAAP income from operations to be between $87 million and $92 million*Non-GAAP earnings per diluted share between $1.43 to $1.48
This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.


*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and tax benefit adjustments.However, these estimates are based on management's current estimates, which may be updated. The Current Situation in IsraelRegarding the current situation in Israel, on October 9, 2025, a new cease-fire agreement between Hamas and Israel began, and the hostilities have formally paused after two years of conflicts. The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. Use of Non-GAAP Financial MeasuresIn addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.Conference Call InformationMr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer and Mr. Yair Malca, Chief Financial Officer, will host a conference call today, February 10, 2026, at 8:30 a.m. Eastern Time to discuss the fourth quarter and full year 2025 financial results.The Company encourages participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10205326/10099498542.Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.U.S. Toll-Free Dial-in Number: 1-833-316-0562
Israel Toll- Free Dial-in Number: 1-80-921-2373
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Q835bTWkAt:
8:30 a.m. Eastern Time
5:30 a.m. Pacific TimeThe conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A reply of the conference call will be available from February 10, 2026, at 12 p.m. Eastern Time to February 24 , 2026, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: Replay Dial-in U.S./Canada TOLL-FREE: 1-855-669-9658
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 9741895To access the replay using an international dial-in number, please select the link below:https://services.choruscall.com/ccforms/replay.htmlA replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.About InModeInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.Forward-Looking Statements The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2026 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 4, 2025, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release. Company Contact:Yair MalcaChief Financial OfficerPhone: (949) 305-0108Email: Yair.Malca@inmodemd.com Investor Relations Contact:Miri SegalMS-IR LLCEmail: ir@inmodemd.com INMODE LTD.CONDENSED CONSOLIDATED STATEMENTS OF INCOME(U.S. dollars in thousands, except for per share data)(Unaudited)
Three months ended
December 31,
Year Ended
December 31,
2025
2024
2025
2024REVENUES103,854
97,853
370,495
394,818COST OF REVENUES22,554
20,216
79,525
77,752GROSS PROFIT81,300
77,637
290,970
317,066OPERATING EXPENSES:






Research and development3,509
2,667
13,319
13,137Sales and marketing48,407
44,653
180,578
181,366General and administrative3,393
2,453
11,686
10,032TOTAL OPERATING EXPENSES55,309
49,773
205,583
204,535OPERATIONS INCOME25,991
27,864
85,387
112,531Finance income, net5,301
4,346
24,943
30,938INCOME BEFORE INCOME TAXES31,292
32,210
110,330
143,469INCOME TAXES BENEFIT (EXPENSES)(4,267)
50,561
(16,499)
37,806NET INCOME27,025
82,771
93,831
181,275







EARNINGS PER SHARE:






Basic0.43
1.15
1.45
2.29Diluted0.42
1.14
1.43
2.25WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING USED IN COMPUTATION OF
EARNINGS PER SHARE (in thousands)






Basic63,335
71,874
64,633
79,306Diluted64,082
72,787
65,445
80,597  INMODE LTD.CONDENSED CONSOLIDATED BALANCE SHEETS(U.S. dollars in thousands, except for per share data)(Unaudited)
December 31,
2025
December 31,
2024Assets


CURRENT ASSETS:


Cash and cash equivalents302,543
155,329Marketable securities (amortized cost of $83,542 and $268,129, as of
December 31, 2025 and 2024, respectively)83,632
267,688Short-term bank deposits169,159
173,455Accounts receivable, net of allowance for credit losses of $2,371 and
$1,825, as of December 31, 2025 and 2024, respectively43,504
36,335Prepaid expenses and other receivables25,733
22,097Inventories74,050
59,548         TOTAL CURRENT ASSETS698,621
714,452    NON-CURRENT ASSETS:


Accounts receivable, net of allowance for credit losses of $856 and $924
as of December 31, 2025 and 2024, respectively3,005
3,176Deferred income tax asset53,230
56,285Operating lease right-of-use assets 8,274
8,732Property and equipment, net2,599
2,322Other investments700
700TOTAL NON-CURRENT ASSETS67,808
71,215TOTAL ASSETS766,429
785,667Liabilities and shareholders' equity


CURRENT LIABILITIES:


Accounts payables17,912
13,782Contract liabilities12,093
16,755Other liabilities40,739
39,314TOTAL CURRENT LIABILITIES70,744
69,851    NON-CURRENT LIABILITIES:


Contract liabilities3,043
3,336Other liabilities4,436
3,356Operating lease liabilities5,008
5,311TOTAL NON-CURRENT LIABILITIES12,487
12,003TOTAL LIABILITIES83,231
81,854



TOTAL SHAREHOLDERS' EQUITY683,198
703,813TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY766,429
785,667  INMODE LTD.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(U.S. dollars in thousands, except for per share data)(Unaudited)

Three months ended
December 31,
Year Ended
December 31,
2025
2024
2025
2024
CASH FLOWS FROM OPERATING ACTIVITIES:







Net income 27,025
82,771
93,831
181,275
Adjustments required to reconcile net income to net cash provided by operating activities:







Depreciation 174
248
695
728
Share-based compensation expenses2,499
3,447
11,131
16,569
Change in allowance for credit losses of trade receivable295
158
454
572
Loss (Gain) on marketable securities, net1
(3)
15
167
Finance expenses (income), net(762)
1,533
498
(4,401)
Deferred income tax assets, net864
(55,121)
2,928
(55,179)
Changes in operating assets and liabilities:







Decrease (increase) in accounts receivable (current and non-current)(6,358)
4,025
(7,452)
5,949
Decrease (increase) in other receivables(1,275)
1,879
(3,678)
(5,698)
Increase in inventories(2,647)
(1,264)
(14,502)
(14,453)
Increase (decrease) in accounts payable1,188
(531)
4,129
(184)
Increase (decrease) in other liabilities (current and non-current)4,759
(4,243)
2,163
1,917
Increase (decrease) in contract liabilities (current and non-current)(3,089)
(457)
(4,955)
5,402
Net cash provided by operating activities22,674
32,442
85,257
132,664
CASH FLOWS FROM INVESTING ACTIVITIES:







   Investment in short-term deposits(113,733)
(3,500)
(292,637)
(168,187)
   Proceeds from short-term deposits103,389
67,100
293,076
218,740
   Purchase of fixed assets(534)
(234)
(972)
(669)
   Purchase of marketable securities–
(59,708)
(20,877)
(336,221)
   Proceeds from sale of marketable securities–
21,146
17,214
90,754
   Proceeds from maturity of marketable securities38,101
53,012
190,228
357,789
Net cash provided by investing activities27,223
77,816
186,032
162,206
CASH FLOWS FROM FINANCING ACTIVITIES:







  Repurchase of ordinary shares-
(119,849)
(127,444)
(285,385)
       Exercise of options137
1,420
1,385
2,614
Net cash provided by (used in) financing activities137
(118,429)
(126,059)
(282,771)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS72
(1,338)
1,984
(1,181)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS50,106
(9,509)
147,214
10,918
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR                        252,437
164,838
155,329
144,411
CASH AND CASH EQUIVALENTS AT END OF YEAR302,543
155,329
302,543
155,329
 INMODE LTD.CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS(U.S. dollars in thousands, except for per share data)(Unaudited)
Three months ended December 31,
Year ended December 31,2025

2024

2025

2024Revenues by Category:






























Capital Equipment revenues - United States46,760
45 %
53,128
55 %
162,158
44 %
204,520
52 %Capital Equipment revenues - International35,631
34 %
24,836
25 %
126,960
34 %
111,027
28 %Total Capital Equipment revenues82,391
79 %
77,964
80 %
289,118
78 %
315,547
80 %Consumables and service revenues21,463
21 %
19,889
20 %
81,377
22 %
79,271
20 %Total Revenue103,854
100 %
97,853
100 %
370,495
100 %
394,818
100 %


















 
Three months ended December 31,
Year ended December 31,2025
2024
2025
2024
%
%
%
%
United States
International
Total
United States
International
Total
United States
International
Total
United States
International
TotalRevenues by Technology:






















Minimal-Invasive76
75
76
93
76
86
78
78
78
92
80
87Hands-Free 1
2
1
5
3
5
3
2
2
6
3
5Non-Invasive23
23
23
2
21
9
19
20
20
2
17
8
100
100
100
100
100
100
100
100
100
100
100
100  INMODE LTD.RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME (U.S. dollars in thousands, except for per share data)(Unaudited)




Three months ended December 31, 2025

Three months ended December 31, 2024GAAP
Share Based
Compensation
Non-GAAP
GAAP
Share Based
Compensation
Tax benefit (1)
Non-GAAPREVENUES103,854
-
103,854
97,853
-
-
97,853COST OF REVENUES22,554
(346)
22,208
20,216
(472)
-
19,744GROSS PROFIT81,300
346
81,646
77,637
472
-
78,109OPERATING EXPENSES:












Research and development3,509
(256)
3,253
2,667
(300)
-
2,367Sales and marketing48,407
(1,589)
46,818
44,653
(2,360)
-
42,293General and administrative3,393
(308)
3,085
2,453
(315)
-
2,138TOTAL OPERATING
EXPENSES55,309
(2,153)
53,156
49,773
(2,975)
-
46,798OPERATIONS INCOME25,991
2,499
28,490
27,864
3,447
-
31,311Finance income, net5,301
-
5,301
4,346
-
-
4,346INCOME BEFORE INCOME TAXES31,292
2,499
33,791
32,210
3,447
-
35,657INCOME TAXES BENEFIT (EXPENSES)(4,267)
(95)
(4,362)
50,561
-
(55,137)
(4,576)NET INCOME27,025
2,404
29,429
82,771
3,447
(55,137)
31,081













EARNINGS PER SHARE:












Basic0.43


0.46
1.15




0.43Diluted0.42


0.46
1.14




0.42WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)












Basic63,335


63,335
71,874




71,874Diluted64,082


64,443
72,787




73,139















(1) Tax benefit recorded during the year ended December 31, 2024, as a result of a release of valuation allowance on our deferred tax assets in the United States as it is more likely than not that our net deferred tax assets will be realized given our expectation of profitability in future periods.  
Year Ended December 31, 2025
Year Ended December 31, 2024GAAP
Share Based
Compensation
Non-GAAP

GAAP
Share Based
Compensation
Tax benefit (1)
Non-GAAPREVENUES370,495


370,495

394,818
-
-
394,818COST OF REVENUES79,525
(1,333)
78,192

77,752
(1,833)
-
75,919GROSS PROFIT290,970
1,333
292,303

317,066
1,833
-
318,899OPERATING EXPENSES:













Research and development13,319
(1,039)
12,280

13,137
(2,177)
-
10,960Sales and marketing180,578
(7,685)
172,893

181,366
(11,367)


169,999General and administrative11,686
(1,074)
10,612

10,032
(1,192)
-
8,840TOTAL OPERATING
EXPENSES205,583
(9,798)
195,785

204,535
(14,736)
-
189,799OPERATIONS INCOME85,387
11,131
96,518

112,531
16,569
-
129,100Finance income, net24,943
-
24,943

30,938
-
-
30,938INCOME BEFORE INCOME TAXES110,330
11,131
121,461

143,469
16,569
-
160,038INCOME TAXES BENEFIT (EXPENSES)(16,499)
533
(15,966)

37,806
-
(55,137)
(17,331)NET INCOME93,831
11,664
105,495

181,275
16,569
(55,137)
142,707














EARNINGS PER
SHARE:













Basic1.45


1.63

2.29




1.80Diluted1.43


1.60

2.25




1.76WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)













Basic64,633


64,633

79,306




79,306Diluted65,445


65,756

80,597




80,943















(1) Tax benefit recorded during the year ended December 31, 2024, as a result of a release of valuation allowance on our deferred tax assets in the United States as it is more likely than not that our net deferred tax assets will be realized given our expectation of profitability in future periods. Logo - https://mma.prnewswire.com/media/1064477/5779813/InMode_Logo.jpg





View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-reports-fourth-quarter-and-full-year-2025-financial-results-quarterly-gaap-revenue-of-103-9-million-and-full-year-revenue-of-370-5-million-302683050.htmlSOURCE InMode Ltd.

Original: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

InMode shares edge higher as company explores strategic optionsFebruary 2, 2026 10:50 AM
IH Market News
Shares of InMode Ltd. (NASDAQ:INMD) gained about 2.5% in premarket trading on Monday after the company confirmed it is reviewing potential strategic alternatives.The medical technology firm said it has formed a special committee made up of independent directors to manage and oversee the evaluation process. The committee has engaged external legal and financial advisers to assess a range of possibilities, including proposals that may involve third parties or members of management.The update follows recent market speculation, including reports of a non-binding approach from Steel Partners Holdings L.P. to acquire a 51% stake in InMode, as well as comments recently attributed to the company’s chief executive officer.InMode stressed that the review may not lead to any transaction or definitive strategic action and said it does not plan to provide additional commentary on the process unless disclosure is required under applicable laws or regulations.The Israel-based group develops and manufactures radiofrequency-based medical devices used in a variety of aesthetic and minimally invasive procedures. It did not disclose a timeline for the review or specify which strategic paths are under consideration.InMode stock price

Original: InMode shares edge higher as company explores strategic options

Today marked the highest share price in a month. It would be great to see the stock fill a gap up to $29.